Cole Schmidtknecht was 22 when he died of an asthma attack. The parents of Cole Schmidtknecht, 22, are suing his medical insurance company and pharmacy after he died of an asthma attack, allegedly due ...
APPLETON, Wis. -- A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a lawsuit filed by his family. From birth, Cole Schmidtknecht ...
Advair is a combination of two medications, fluticasone and salmeterol, that helps people manage asthma and chronic obstructive pulmonary disease (COPD). By following these 15 steps, you can ensure ...
Lannett has submitted an ANDA to the Food and Drug Administration for its strategic partner, Respirant's fluticasone propionate and salmeterol inhalation powder (100/50 mcg, 250/50 mcg and 500/50 mcg) ...
LONDON, Dec. 17, 2020 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces it has received FDA approval for and launched its generic version of ...
Wixela™ Inhub™ represents a therapeutically equivalent new fluticasone propionate/salmeterol treatment option for use in the treatment of asthma and COPD. Wixela Inhub is a generic equivalent of ...
Mylan N.V. MYL received a significant boost when the FDA approved its generic version of GlaxoSmithKline's GSK Advair Diskus - Wixela Inhub - following a few setbacks. Notably, this is the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback